Functional Fluidics Presented At The Foundation for Sickle Cell Disease Research, April 28-30, Fort Lauderdale, FL

Dr. Patrick Hines chaired an education session on biomarkers and surrogate endpoints at the Foundation for Sickle Cell Disease Research (FSCDR) meeting the weekend of April 28-30th in Fort Lauderdale, FL. In addition to Dr. Hines, the session featured speakers from Pfizer, Wayne State University, Harvard, and Global Blood Therapeutics. The focus of the session was:  “Can Novel Biomarkers Clarify Sickle Cell Disease Status and Effects of Disease-Modifying Therapies? Current Challenges – Future Opportunities (http://sched.co/A8XP)

Dr. Jennell White presented preliminary results from an exciting longitudinal study evaluating standardized adhesion assay data in individuals with SCD on Sunday 4/30. She discussed clinical reference ranges for adhesion in SCD patients and explore how these assays can be useful in clinical studies of SCD-modifying drugs (http://sched.co/A8Xd).

Below is a recording of our presentation on biomarkers and surrogate endpoints: